NEW YORK, Nov. 18 (GenomeWeb News) - NanoInk has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to support the development of its Dip Pen Nanolithography technology for miniaturizing DNA arrays, the company said today.

NanoInk said the grant is the first award of a two-phase $1.3 million award. Phase I SBIR's are generally in the $100,000 range.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.